Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5278]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Pancreatic cancer spreads to liver or lung thanks to this protein
Pancreatic cancer spreads to liver or lung thanks to this protein
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study...
ASCO 2025: Adding niraparib to standard treatment may slow cancer growth for some patients with mCSPC
ASCO 2025: Adding niraparib to standard treatment may slow cancer growth for some patients with mCSPC
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer without cancer progression
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer...
ASCO 2025: Post-hoc analysis demonstrates patient characteristics associated with long-term overall survival with irinotecan liposome injection in metastatic pancreatic adenocarcinoma
ASCO 2025: Post-hoc analysis demonstrates patient characteristics associated with long-term overall survival with...
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
ASCO 2025: Trial shows biomarkers hold clue in treating aggressive prostate cancer
ASCO 2025: Trial shows biomarkers hold clue in treating aggressive prostate cancer
ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients...
ASCO 2025: Study highlights potential new treatment for aggressive form of acute myeloid leukaemia
ASCO 2025: Study highlights potential new treatment for aggressive form of acute myeloid leukaemia
New biomarker may guide best use of KRAS inhibitors in lung cancer
New biomarker may guide best use of KRAS inhibitors in lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation